WallStreetZenWallStreetZen

AnalystsRobert Burns
Robert Burns's Stock Forecasts

Analyst Ranking
Bottom 1%
#4164 out of 4174 analysts
Average Return
-18.77%
Win Rate
27%33 out of 122
Risk vs Reward
Poor
Good

Robert Burns's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunomedics IncIMMU
+342.36%$18.91$83.65
2020-04-07 -
2020-09-14
Buy
Turning Point Therapeutics IncTPTX
+208.74%$35.13$108.46
2020-03-17 -
2021-03-17
Buy
Immunomedics IncIMMU
+158.98%$32.30$83.65
2020-05-07 -
2020-09-14
Buy
Turning Point Therapeutics IncTPTX
+153.91%$29.44$74.75
2022-03-22 -
2022-06-06
Buy
Springworks Therapeutics IncSWTX
+143.31%$29.88$72.70
2020-04-14 -
2021-04-14
Buy

Robert Burns Analyst Color

Get additional color on Robert Burns's coverage of popular stocks

Robert Burns's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Zymeworks IncZYME
8Hold$8.00-15.61%Reiterates
13 days ago
Fate Therapeutics IncFATE
6Hold$7.00+1.89%Downgrades
13 days ago
Adc Therapeutics SaADCT
7Buy$20.00+331.97%Maintains
a month ago
Revolution Medicines IncRVMD
6Buy$32.00+23.55%Maintains
2 months ago
Omega Therapeutics IncOMGA
1Buy$11.00+52.35%Initiates Coverage On
2 months ago
Portage Biotech IncPRTG
3Buy$21.00+356.52%Maintains
2 months ago
Ikena Oncology IncIKNA
3Buy$22.00+455.56%Maintains
2 months ago
Tcr2 Therapeutics IncTCRR
4Buy$13.00+802.78%Maintains
3 months ago
Kronos Bio IncKRON
3Buy$10.00+340.53%Maintains
3 months ago
Prelude Therapeutics IncPRLD
3Buy$15.00+112.46%Maintains
3 months ago
Repare Therapeutics IncRPTX
3Buy$25.00+102.27%Maintains
3 months ago
Pmv Pharmaceuticals IncPMVP
2Buy$36.00+336.89%Maintains
3 months ago
Neoleukin Therapeutics IncNLTX
3HoldN/AN/ADowngrades
3 months ago
Relay Therapeutics IncRLAY
6Buy$43.00+94.83%Maintains
3 months ago
Macrogenics IncMGNX
6Buy$12.00+114.67%Maintains
3 months ago
Igm Biosciences IncIGMS
4Buy$45.00+87.50%Maintains
3 months ago
Replimune Group IncREPL
2Buy$48.00+69.67%Maintains
3 months ago
Springworks Therapeutics IncSWTX
9Buy$99.00+212.40%Maintains
3 months ago
Y Mabs Therapeutics IncYMAB
4Buy$19.00+305.98%Maintains
3 months ago
Tango Therapeutics IncTNGX
1Buy$10.00+52.91%Initiates Coverage On
4 months ago
Nurix Therapeutics IncNRIX
4Buy$53.00+323.32%Maintains
4 months ago
Gt Biopharma IncGTBP
2Buy$5.00+458.66%Maintains
5 months ago
Forma Therapeutics Holdings IncFMTX
2Hold$20.00-0.05%Downgrades
5 months ago
Nuvation Bio IncNUVB
2Buy$4.50+87.50%Maintains
5 months ago
Caribou Biosciences IncCRBU
2Buy$27.00+255.26%Maintains
6 months ago
Biontech SeBNTX
10Buy$272.00+91.47%Maintains
6 months ago
Kinnate Biopharma IncKNTE
1Buy$33.00+338.83%Initiates Coverage On
6 months ago
Turning Point Therapeutics IncTPTX
6Hold$76.00-0.01%Downgrades
8 months ago
Atara Biotherapeutics IncATRA
3Buy$29.00+460.93%Maintains
8 months ago
Aadi Bioscience IncAADI
4Buy$48.00+283.08%Maintains
10 months ago
Oric Pharmaceuticals IncORIC
6HoldN/AN/ADowngrades
10 months ago
Black Diamond Therapeutics IncBDTX
2HoldN/AN/ADowngrades
10 months ago
Cytomx Therapeutics IncCTMX
1Buy$11.00N/AMaintains
a year ago
Nucana PLCNCNA
2Buy$9.00N/AMaintains
a year ago
Molecular Partners AgMOLN
1Buy$25.00N/AAssumes
2 years ago
Viracta Therapeutics IncVIRX
1Buy$35.00N/AInitiates Coverage On
2 years ago
Allogene Therapeutics IncALLO
1Buy$43.00N/AMaintains
2 years ago
Autolus Therapeutics PLCAUTL
1Buy$13.00N/AMaintains
2 years ago
Immunomedics IncIMMU
4Hold$88.00N/ADowngrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.